Fact Source: Financial Supervisory Service DART / 2025-03-31
Disclosure Type: Sales / Supply Contract
💡 Summary in 3 Seconds
Hanwha Systems has signed a supply contract worth KRW 157.9B with its largest shareholder, Hanwha Aerospace, for the K21 Infantry Fighting Vehicle 4th Mass Production Purchase Agreement.
📊 1. [Key Disclosure Details & Financial Highlights]
- Contract Name: K21 Infantry Fighting Vehicle 4th Mass Production Purchase Agreement (CP24113)
- Contract Amount: KRW 157,914,266,106 (VAT included / approx. KRW 157.9B)
- Relative Size to Revenue: 6.44% (Based on 2023 consolidated annual revenue of KRW 2.45T)
- Counterparty: Hanwha Aerospace Co., Ltd. (Relationship: Largest Shareholder)
- Supply Region: Domestic (Republic of Korea)
- Contract Period: March 31, 2025 ~ September 15, 2028 (approx. 3 years and 5 months)
- Payment Terms: 90-day promissory note (Down payment/advance payment included)
- Contract Date: March 31, 2025
- Other Notes: Contract amount and duration remain subject to changes depending on project progress.
📈 2. [Professional Insight: What This Means for Investors]
This filing details an intercompany sales and supply contract executed between Hanwha Systems and its largest shareholder, Hanwha Aerospace Co., Ltd. Financially, the contract amount of approx. KRW 157.9B represents 6.44% of Hanwha Systems’ 2023 consolidated annual revenue (approx. KRW 2.45T).
The contract period spans approximately 3 years and 5 months, running from March 31, 2025 to September 15, 2028, with payment specified via 90-day promissory notes. Beyond the figures provided in the filing, specific revenue recognition schedules or profitability details are not disclosed, and contract terms remain subject to potential adjustment depending on execution.
📝 Editor’s Comment (by K-STOCK Editor)
The objective fact established in this disclosure is that Hanwha Systems secured a KRW 157.9B supply contract with its largest shareholder for the K21 IFV 4th mass production run, equivalent to 6.44% of its 2023 annual revenue.
Moving forward, the primary objective checkpoints for investors are tracking contract execution through the scheduled completion date of September 15, 2028, and monitoring for any subsequent regulatory amendment filings. As the disclosure notes that contract terms may shift depending on progress, tracking the implementation timeline remains the reference point.
📢 Disclaimer & Source Notice
Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
